Centerbridge said to seek Versant Health exit, could pass $2bn valuation


Centerbridge Partners is reportedly working on a potential sale of Versant Health in a deal which could see the managed vision care benefits business valued at more than $2bn.

The private equity house has hired Barclays to run an auction for Versant according to Reuters, which cited unnamed people it said were familiar with the matter.

Centerbridge created Versant two years ago through the merger of Superior Vision and Davis Vision.

Other recent deal activity from Centerbridge has included agreeing to buy into health insurance marketplace GoHealth in August, in a deal Reuters suggested at the time was worth about $1.5bn.

The firm has been hotly tipped to come back to market with a weighty new fund soon, having closed its most recent flagship vehicle, Fund III on $6bn back in 2014.

Centerbridge held an $894m final close for its debut real estate fund in February this year.

Copyright © 2019 AltAssets

Get the latest PE News & Research delivered to your inbox every morning